Journals A-Z
All Subjects
Free Journals
sciepub.com
Journal of Cancer Research and Treatment ISSN (Print): 2374-1996 ISSN (Online): 2374-2003 Website: http://www.sciepub.com/journal/jcrt
Editor-in-chief: Jean Rommelaere
Submit an article Join Peer-Review Program
Publications are Open
Access in this journal

Latest Articles

Open AccessArticle
Export: RIS | BibTeX | EndNote
Gene Expression of OCT4 and NANOG Correlated with Advanced Stage and Worse Survival in Breast Cancer Patients
by Fawziya A. R Ibrahim, Shaymaa E. El Feky, Kadhim K. Kadhim, Nadia A. Abd El Moneim, Mohammad A. Ahmmad and Salah A. Sheweita
Journal of Cancer Research and Treatment. 2019, 7(2), 36-43. DOI: 10.12691/jcrt-7-2-1
Pub. Date: October 24, 2019
breast cancer stemness markers Oct-4 NANOG prognosis
Abstract Full Text PDF (236 KB) Full Text HTML Full Text ePUB (370 KB)
Open AccessArticle
Export: RIS | BibTeX | EndNote
Antiproliferative Effect on Cancer Cells of Novel Pink Red-like Pigments and Derivatives Produced by Streptomyces coelicoflavus Strains
by Assia Mouslim, Saad Menggad, Norddine Habti, El Bachir Affar and Mohammed Menggad
Journal of Cancer Research and Treatment. 2019, 7(1), 27-33. DOI: 10.12691/jcrt-7-1-5
Pub. Date: October 11, 2019
pigment anthracycline antiproliferative cancer cells cycle phase arrest S. coelicoflavus
Abstract Full Text PDF (269 KB) Full Text HTML Full Text ePUB (536 KB)
Figure of 4
Open AccessReview Article
Export: RIS | BibTeX | EndNote
The Nanoformulations of Curcumin for Cancer Therapy: New Perspectives
by Aisha H. Al-Shehri, Ahmed M. Kabel and Maaly A. Abd Elmaaboud
Journal of Cancer Research and Treatment. 2019, 7(1), 21-26. DOI: 10.12691/jcrt-7-1-4
Pub. Date: August 23, 2019
curcumin nanoformulations cancer perspectives
Abstract Full Text PDF (151 KB) Full Text HTML Full Text ePUB (38 KB)
Open AccessMini Review
Export: RIS | BibTeX | EndNote
Doxorubicin: Insights into Dynamics, Clinical Uses and Adverse Effects
by Amal A. Alghorabi, Ahmed M. Kabel and Maaly A. Abd Elmaaboud
Journal of Cancer Research and Treatment. 2019, 7(1), 17-20. DOI: 10.12691/jcrt-7-1-3
Pub. Date: July 24, 2019
doxorubicin dynamics uses toxicity
Abstract Full Text PDF (109 KB) Full Text HTML Full Text ePUB (108 KB)
Open AccessArticle
Export: RIS | BibTeX | EndNote
VEGF and KRAS are Potential Targets of miR-206 Modulation in Triple Negative Breast Cancer
by Shaymaa E. El Feky, Fawziya A.R. Ibrahim, Adel Nassar, Nadia A. Abd El Moneim, Samia A. Ebeid, Mohammad A. Ahmad, Sanaa Shawky and Mohammad M. Nasef
Journal of Cancer Research and Treatment. 2019, 7(1), 10-16. DOI: 10.12691/jcrt-7-1-2
Pub. Date: July 16, 2019
triple negative breast cancer miR-206 VEGF KRAS epigenetic regulation
Abstract Full Text PDF (386 KB) Full Text HTML Full Text ePUB (306 KB)
Figure of 4
Manuscript template